Sort
261,768 grants matching “gene therapy”
Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
$990,891Peter Galen · Hemex Health, Inc. · R44 · FY2025 · HL
A Multi-Center Study To Map Genes for Fuchs'Dystrophy
$990,775Case Western Reserve University · R01 · FY2005 · EY
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$990,771Michael T Barrett · Binary Genomics, Inc. · R44 · FY2024 · CA
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
$990,702Timothy W Schacker · University Of Minnesota · U01 · FY2017 · AI
Phospholipid and Sphingolipid Signaling in Drosophila
$990,585Jairaj Acharya · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$990,493Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2008 · AI
Probing Systems-Level Function of Fronto-Temporal
$990,470New York University · P50 · FY2004 · MH
Arizona Center for Education and Research on Therapeutics
$990,461Raymond L Woosley · Critical Path Institute · U18 · FY2007 · HS
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer
$990,371David B Agus · Stanford University · U54 · FY2008 · CA
Gerome Wide Association Study of Bacterial Determinants of Clinical Response in Tuberculosis
$990,349Megan B Murray · Harvard Medical School · U19 · FY2022 · AI
Development and Preclinical Application of Pancreatic Adenocarcinoma Models
$990,320Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
$990,311Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
Administrative Core
$990,300Dennis L. Kasper · Harvard Medical School · U54 · FY2013 · AI
Image-guided dosimetry-based alpha particle therapy for neuroblastoma.
$990,225Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2022 · CA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$990,110Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$990,050Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2012 · HL
Scalable Development of Custom Genome Editing Technologies
$990,000Benjamin Peter Kleinstiver · Massachusetts General Hospital · DP2 · FY2025 · CA
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$989,984Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Mass Spectrometry Quantitation
$989,919Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$989,903Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA
Clinical Trials with Immunotoxins
$989,879Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
SBIR Phase II: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes
$989,854Michael Koeris · Vulcan Biologics, Inc. · · FY2021 · TIP
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$989,826Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2021 · CA
A multi-scale approach to airway hyperresponsiveness: from molecule to organ
$989,697Michael J. Sanderson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · HL